TellMed Strategies

We're in the holiday spirit and would like to take a moment to express our heartfelt gratitude to our incredible clients and partners. It’s been an inspiring year working alongside those who are dedicated to advancing healthcare and bringing innovative solutions to patients in need.    May the New Year bring continued success, health, and happiness to you, your teams, and the patients whose lives you’re impacting. #TeamTellMed #HappyHolidays

This year’s Massachusetts Conference for Women was an inspiring event that offered invaluable lessons on #leadership, financial wellness, #worklifebalance, and mental and emotional health in the workplace. From the motivating keynote discussions to the intimate breakout sessions, we’re grateful for this opportunity to grow, explore ways to better serve our clients, and reflect on how to create meaningful change in our workplace and beyond. Stay tuned as we put insights from the meeting into action.   #TeamTellMed #MassWomen #TeamBuilding #ProfessionalDevelopment

#TeamTellMed loves working with patient-driven organizations like the Lupus Research Alliance who share our passion to improve lives through their innovative research and star-studded fundraising events like their #BreakingThroughGala. Congratulations on a successful evening and thank you for all you do for the #lupus community!    #patientadvocacy 

It’s a wrap on #AHA24!   ✅ Organized a well-attended AHA Learning Studio program on gene therapy for CHF ✅ Arranged media interviews related to AskBio's investigational gene therapy ✅ Participated in CPR mini-training outside the press room ✅ Supported patient advocacy meetings ✅ Ate at the Navy Pier!

We are proud to have walked alongside Lantheus for the #HeartWalk. Heart disease remains a leading cause of death in the U.S., and we take pride in the work this client is doing to save lives in the clinic and for these walks. #TeamTellMed

Happy Halloween from all of us at TellMed!! #TeamTellMed

ICYMI: Last month, Centers for Medicare & Medicaid Services announced their proposed rule changes for 2025, which could improve access to advanced imaging techniques using diagnostic radiopharmaceuticals.    Innovative companies such as Lantheus have made incredible leaps in imaging technology, and we applaud CMS’ recognition of the benefits diagnostic radiopharmaceuticals can deliver to patients.    Check out this article from Radiology Business to learn more: https://bit.ly/4fphQr4   #lifesciences #innovation #diagnosticimaging #radiopharmaceuticals #FindFightFollow #TeamTellMed

ICYMI: Lantheus recently acquired Meilleur Technologies, strengthening its #diagnostics pipeline for #AlzheimersDisease. We find ourselves invigorated every day to support the innovative work of companies such as Lantheus.   Learn more about their latest acquisition: https://bit.ly/46pchVq

Recently, Halsey bravely and openly announced their #lupus diagnosis and their donation to our client, Lupus Research Alliance. Thank you to Halsey for their bravery and to Jenna Fanelli from Woman’s World for writing a detailed, accurate, informative and thoughtful story about this news. Great work Jenna and Caren Begun!   #nonprofit #lupus #medicalresearch #patientadvocacy #publicrelations #TeamTellMed Lupus Research Alliance

Congratulations to Yale University professor and RIGImmune Inc. co-founder Akiko Iwasaki, who was named one of Time Inc.’s 100 Most Influential People of 2024 for her work in #immunology, including her leading role in understanding and fighting Long COVID. If you are interested in hearing some of Dr. Iwasaki’s perspectives, and her personal experience with alpha-gal syndrome AGS, an allergy to red meat that can be caused by a tick bite, check out this TickTective interview by our client Bay Area Lyme Foundation, which just posted this week. https://bit.ly/3UUdj6L Among her many awards, Dr. Iwasaki was recognized by our client Lupus Research Alliance as its 2022 Lupus Insight Prize recipient. And, we are incredibly honored to work with the company Dr. Iwasaki co-founded, RIGImmune, based in part on her research into mechanisms of immune defense at mucosal surfaces. She is incredibly deserving of this award, and we are excited for where her research is headed. #TIME100 #immunotherapeutics #awards #RNATherapeutics #drugdiscovery